Open AccessSecond-line treatment of hepatocellular carcinoma: from theory to practical issues
Author(s) -
В. В. Бредер,
К. К. Лактионов
Publication year - 2019
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2019-19-30-36
Subject(s) - lenvatinib , sorafenib , medicine , regorafenib , ramucirumab , cabozantinib , hepatocellular carcinoma , nivolumab , oncology , pembrolizumab , clinical endpoint , clinical trial , placebo , immunotherapy , cancer , pathology , colorectal cancer , alternative medicine